Xiaokun Shen

2.0k total citations
43 papers, 1.2k citations indexed

About

Xiaokun Shen is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xiaokun Shen has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in Xiaokun Shen's work include Cancer-related molecular mechanisms research (7 papers), Hepatitis B Virus Studies (5 papers) and Immune Cell Function and Interaction (5 papers). Xiaokun Shen is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Hepatitis B Virus Studies (5 papers) and Immune Cell Function and Interaction (5 papers). Xiaokun Shen collaborates with scholars based in China, United States and Singapore. Xiaokun Shen's co-authors include Yong Song, Kan Ding, Tangfeng Lv, Ping Zhan, Xiaohui Miao, Yanling Lv, Dongmei Yuan, Jianping Fang, Bojian Xie and Li Yu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaokun Shen

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaokun Shen China 18 643 320 243 164 149 43 1.2k
Nidhi Gupta India 23 580 0.9× 207 0.6× 302 1.2× 90 0.5× 93 0.6× 72 1.3k
Xuan Xu China 21 773 1.2× 290 0.9× 160 0.7× 94 0.6× 140 0.9× 63 1.4k
Jeng‐Wei Lu Taiwan 24 759 1.2× 313 1.0× 210 0.9× 177 1.1× 109 0.7× 95 1.6k
Wendong Wang China 20 753 1.2× 410 1.3× 351 1.4× 173 1.1× 265 1.8× 46 1.4k
Xiang Pan China 21 773 1.2× 577 1.8× 107 0.4× 108 0.7× 156 1.0× 90 1.5k
Fangzhou Song China 24 1.0k 1.6× 472 1.5× 244 1.0× 112 0.7× 168 1.1× 69 1.5k
Sofia Mubarika Haryana Indonesia 20 392 0.6× 233 0.7× 371 1.5× 118 0.7× 82 0.6× 104 1.1k
Yuhan Liu China 18 768 1.2× 417 1.3× 157 0.6× 143 0.9× 132 0.9× 81 1.3k
Maria Cristina Dechecchi Italy 24 836 1.3× 250 0.8× 213 0.9× 162 1.0× 440 3.0× 35 1.6k
Hong Gao China 15 385 0.6× 215 0.7× 190 0.8× 211 1.3× 104 0.7× 59 1.1k

Countries citing papers authored by Xiaokun Shen

Since Specialization
Citations

This map shows the geographic impact of Xiaokun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaokun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaokun Shen more than expected).

Fields of papers citing papers by Xiaokun Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaokun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaokun Shen. The network helps show where Xiaokun Shen may publish in the future.

Co-authorship network of co-authors of Xiaokun Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaokun Shen. A scholar is included among the top collaborators of Xiaokun Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaokun Shen. Xiaokun Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunyan, et al.. (2025). A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy. PubMed. 8(3). 189–196. 1 indexed citations
2.
Wen-ying, Huang, et al.. (2025). Activation of GLP-1 receptors enhances the osteogenic differentiation process of STRO-1-positive BMSCs. Molecular Biology Reports. 52(1). 559–559. 1 indexed citations
3.
Li, Fujie, et al.. (2024). Vascular endothelial growth factor facilitates the effects of telocytes on tumor cell proliferation and migration. Frontiers in Cell and Developmental Biology. 12. 1474682–1474682. 2 indexed citations
4.
Li, Fujie, et al.. (2022). TLR2 agonist promotes myeloid-derived suppressor cell polarization via Runx1 in hepatocellular carcinoma. International Immunopharmacology. 111. 109168–109168. 21 indexed citations
5.
Li, Xinmei, Yifan Zhang, Xia‐Juan Huan, et al.. (2022). Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats. Cancer Chemotherapy and Pharmacology. 90(6). 499–510. 1 indexed citations
6.
Shen, Xiaokun, Huiyun Zhang, Hua Xie, et al.. (2021). Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma. Frontiers in Immunology. 12. 710750–710750. 22 indexed citations
7.
Fu, Binqing, Dongyao Wang, Xiaokun Shen, et al.. (2020). Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells. Frontiers in Immunology. 11. 591269–591269. 12 indexed citations
8.
Yang, Ying, Xun Sun, Chi Chen, et al.. (2019). Upregulation of long noncoding RNA LINC00152 promotes proliferation and metastasis of esophageal squamous cell carcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Xu, Qi, Xiaoya Yuan, Tiantian Gu, et al.. (2017). Comparative characterization of bacterial communities in geese fed all-grass or high-grain diets. PLoS ONE. 12(10). e0185590–e0185590. 23 indexed citations
10.
Wang, Jiwen, Han Liu, Xiaokun Shen, et al.. (2017). Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis. Oncology Letters. 13(5). 3508–3516. 15 indexed citations
11.
Lü, Wei, Feixiong Cheng, Wanfeng Yan, et al.. (2017). Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA. Oncogene. 36(33). 4719–4731. 20 indexed citations
12.
Shen, Xiaokun, Binqing Fu, Yanyan Liu, et al.. (2016). NKp30+ NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B. Scientific Reports. 6(1). 38778–38778. 14 indexed citations
13.
Guo, Chuang, Xiaokun Shen, Binqing Fu, et al.. (2016). CD3brightCD56+ T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients. Scientific Reports. 6(1). 25567–25567. 7 indexed citations
14.
Shen, Xiaokun, Beibei Chen, Bojian Xie, et al.. (2015). A systematic analysis of the resistance and sensitivity of HER2YVMAreceptor tyrosine kinase mutant to tyrosine kinase inhibitors in HER2-positive lung cancer. Journal of Receptors and Signal Transduction. 36(1). 89–97. 7 indexed citations
15.
Fang, Jianping, et al.. (2012). Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling. Glycoconjugate Journal. 29(5-6). 365–377. 89 indexed citations
16.
Lv, Tangfeng, Dongmei Yuan, Xiaohui Miao, et al.. (2012). Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer. PLoS ONE. 7(4). e35065–e35065. 232 indexed citations
17.
Zhan, Ping, Xiaokun Shen, Qian Qian, et al.. (2011). Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas. Medical Oncology. 29(2). 648–655. 31 indexed citations
18.
Shen, Xiaokun, Jianping Fang, Zhichao Pei, et al.. (2011). Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b. Journal of Biological Chemistry. 286(30). 26616–26627. 65 indexed citations
19.
Zhan, Ping, Lijun Suo, Qian Qian, et al.. (2010). Chlamydia pneumoniae infection and lung cancer risk: A meta-analysis. European Journal of Cancer. 47(5). 742–747. 75 indexed citations
20.
Li, Yan, Li‐Xin Qiu, Xiaokun Shen, et al.. (2009). A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: Evidence from 15,857 subjects. Lung Cancer. 66(1). 15–21. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nidhi Gupta Breakdown of academic impact, for papers by Xuan Xu Breakdown of academic impact, for papers by Jeng‐Wei Lu Breakdown of academic impact, for papers by Wendong Wang Breakdown of academic impact, for papers by Xiang Pan Breakdown of academic impact, for papers by Fangzhou Song Breakdown of academic impact, for papers by Sofia Mubarika Haryana Breakdown of academic impact, for papers by Yuhan Liu Breakdown of academic impact, for papers by Maria Cristina Dechecchi Breakdown of academic impact, for papers by Hong Gao
Rankless by CCL
2026